BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 29878375)

  • 1. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
    Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
    J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Upper Abdominal Surgery on Complication Profile in Ovarian Cancer.
    Kiran G; Tanoglu FB; Cetin C; Pasin O
    Chirurgia (Bucur); 2023 Jun; 118(3):281-290. PubMed ID: 37480354
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.
    Cordeiro Vidal G; Babin G; Querleu D; Guyon F
    Gynecol Oncol; 2017 Jan; 144(1):223-224. PubMed ID: 27836207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
    Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study.
    Ren Y; Jiang R; Yin S; You C; Liu D; Cheng X; Tang J; Zang R
    BMC Cancer; 2015 Aug; 15():583. PubMed ID: 26268818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
    Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
    Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning curve of high-complexity surgery for advanced ovarian cancer.
    Nishikimi K; Tate S; Matsuoka A; Shozu M
    Gynecol Oncol; 2020 Jan; 156(1):54-61. PubMed ID: 31735352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
    Eisenkop SM; Friedman RL; Wang HJ
    Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery.
    Benedetti Panici P; Di Donato V; Fischetti M; Casorelli A; Perniola G; Musella A; Marchetti C; Palaia I; Berloco P; Muzii L
    Gynecol Oncol; 2015 Jun; 137(3):406-11. PubMed ID: 25824857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimal time for surgery in women with serous ovarian cancer.
    Stewart JM; Tone AA; Jiang H; Bernardini MQ; Ferguson S; Laframboise S; Murphy KJ; Rosen B; May T
    Can J Surg; 2016 Aug; 59(4):223-32. PubMed ID: 27240134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
    Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
    Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
    Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian Cancer.
    Martinez A; Ngo C; Leblanc E; Gouy S; Luyckx M; Darai E; Classe JM; Guyon F; Pomel C; Ferron G; Filleron T; Querleu D
    Ann Surg Oncol; 2016 Aug; 23(8):2515-21. PubMed ID: 27008588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is neo-adjuvant chemotherapy a "waiver" of extensive upper abdominal surgery in advanced epithelial ovarian cancer?
    Kang S; Jong YH; Hwang JH; Lim MC; Seo SS; Yoo CW; Park SY
    Ann Surg Oncol; 2011 Dec; 18(13):3824-7. PubMed ID: 21691879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
    Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
    Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes in patients undergoing maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or peritoneal carcinomas.
    Gurkan D; Ceren Akin A; Sahin H; Aytac Tohma Y; Sahin EA; Gunakan E; Iflazoglu N; Nihan Haberal A; Ayhan A
    J Obstet Gynaecol; 2020 May; 40(4):551-557. PubMed ID: 31482736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.
    Gómez-Hidalgo NR; Martinez-Cannon BA; Nick AM; Lu KH; Sood AK; Coleman RL; Ramirez PT
    Gynecol Oncol; 2015 Jun; 137(3):553-8. PubMed ID: 25827290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery.
    Fanfani F; Fagotti A; Gallotta V; Ercoli A; Pacelli F; Costantini B; Vizzielli G; Margariti PA; Garganese G; Scambia G
    Gynecol Oncol; 2010 Mar; 116(3):497-501. PubMed ID: 20004958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
    Kim HS; Bristow RE; Chang SJ
    Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.